10.1002/chem.201605986
Chemistry - A European Journal
FULL PAPER
ppm; HRMS (ESI): m/z calcd for C39H48N6O7+H+: 713.8560 [M+H+];
found: 713.8563.
[3]
a) H. Szmacinski, J. R. Lakowicz, Anal. Biochem. 1997, 250, 131-138;
b) A. P. de Silva, H. Q. N. Gunaratne, T. Gunnlaugsson, M.
Nieuwenhuizen, Chem. Commun. 1996, 1967-1968; c) M. K. Kim, C. S.
Lim, J. T. Hong, J. H. Han, H.-Y. Jang, H. M. Kim, B. R. Cho, Angew.
Chem. Int. Ed. 2010, 49, 364-367; d) A. R. Sarkar, C. H. Heo, M. Y.
Park, H. W. Lee, H. M. Kim, Chem. Commun. 2014, 50, 1309-1312; e)
M. Taki, H. Ogasawara, H. Osaki, A. Fukazawa, Y. Sato, K. Ogasawara,
T. Higashiyama, S. Yamaguchi, Chem. Commun. 2015, 51, 11880-
11883.
2-(16-(1-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazol-4-
yl)-2,3,5,6,8,9,11,12-octahydro-13H-
benzo[k][1,4,7,10]tetraoxa[13]azacyclopentadecin-13-
yl)methylacetate (4): Yield 38% (98 mg); M.p.: 163°C (decomp.); 1H
NMR (CDCl3, 300 MHz): δ = 8.70 (s, 1H), 8.41 (s, 1H), 7.45-7.33 (m, 3H),
6.98 (d, J = 7.5 Hz, 1H), 6.66 (d, J = 8.2 Hz, 1H), 6.54 (s, 1H), 4.26-3.53
(m, 21H), 3.48-3.39 (m, 4H), 1.22 ppm (t, J = 6.8 Hz, 6H); 13C NMR
(CDCl3, 75 MHz): δ = 172.18, 156.89, 155.67, 151.73, 151.43, 147.47,
139.51, 134.32, 129.93, 124.25, 120.51, 119.63, 118.65, 116.86, 110.54,
110.00, 107.05, 96.91, 70.81, 70.63, 70.24, 70.10, 69.62, 68.99, 68.50,
53.48, 52.26, 51.52, 44.94, 12.38 ppm; HRMS (ESI): m/z calcd for
C32H39N5O8+H+: 622.2877 [M+H+]; found: 622.2842.
[4]
[5]
a) H. He, M. A. Mortellaro, M. J. P. Leiner, S. T. Young, Ro. J. Fraatz, J.
K. Tusa, Anal. Chem. 2003, 75, 549-555; b) T. Gunnlaugsson, M.
Nieuwenhuyzen, L. Richard, V. Thoss, Tetrahedron Lett. 2001, 42,
4725–4728.
a) V. V. Martin, A. Rothe, K. R. Gee Bioorg. Med. Chem. Lett. 2005, 15,
1851-1855; b) V. V. Martin, A. Rothe, Z. Diwu, K. R. Gee Bioorg. Med.
Chem. Lett. 2004, 14, 5313-5316; c) F. V. Englich, T. C. Foo, A. C.
Richardson, H. Ebendorff-Heidepriem, C. J. Sumby, T. M. Monro,
Sensors 2011, 11, 9560-9572.
7-(diethylamino)-3-(4-(2,3,5,6,8,9,11,12-
octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecin-15-yl)-1H-
1,2,3-triazol-1-yl)-2H-chromen-2-one (5): Yield 32% (73 mg); M.p.:
184°C (decomp.); 1H-NMR (CDCl3, 300 MHz): δ = 8.72 (s, 1H), 8.42 (s,
1H), 7.53-7.35 (m, 3H), 6.92 (d, J = 8.3 Hz, 1H), 6.66 (dd, J = 8.9, 2.3 Hz,
1H), 6.54 (d, J = 2.1 Hz, 1H), 4.27-4.14 (m, 4H), 3.99-3.89 (m, 4H), 3.75
(s, 8H), 3.44 (q, J = 7.0 Hz, 4H), 1.22 ppm (t, J = 7.0 Hz, 6H); 13C-NMR
(CDCl3, 75 MHz): δ = 156.91, 155.69, 151.45, 149.32, 149.11, 147.38,
134.35, 129.94, 123.81, 119.68, 118.77, 116.85, 114.05, 111.36, 110.03,
107.07, 96.94, 71.10, 71.07, 70.46, 70.43, 69.55, 69.51, 69.01, 68.93,
44.95, 12.38 ppm; HRMS (ESI): m/z calcd for C29H34N4O7+H+: 551.2506
[M+H+]; found: 551.2507.
[6]
[7]
a) P. Nandhikonda, M. P. Begaye, M. D. Heagy, Tetrahedron Lett. 2009,
50, 2459-2461; b) S. Uchiyama, E. Fukatsu, G. D. McClean, A. P. de
Silva, Angew. Chem. 2016, 128, 778-781; Angew. Chem. Int. Ed. 2016,
55, 768-771.
a) S. Ast, H. Müller, R. Flehr, T. Klamroth, B. Walz, H.-J. Holdt, Chem.
Commun. 2011, 47, 4685-4687; b) S. Ast, T. Schwarze, H. Müller, A.
Sukhanov, S. Michaelis, J. Wegener, O. S. Wolfbeis, T. Körzdörfer, A.
Dürkop, H.-J. Holdt, Chem. Eur. J. 2013, 19, 14911-14917; c) T.
Schwarze, J. Riemer, S. Eidner, H.-J. Holdt, Chem. Eur. J. 2015, 21,
11306-11310; d) T. Schwarze, R. Schneider, J. Riemer, H.-J. Holdt,
Chem. Asian J. 2016, 11, 241-247.
[8]
[9]
T. Schwarze, H. Müller, S. Ast, D. Steinbrück, S. Eidner, F. Geißler, M.
U. Kumke, H.-J. Holdt, Chem. Commun. 2014, 50, 14167-14170.
D. Kim, Q. P. Xuan, H. Moon, Y. W. Jun, K. H. Ahn, Asian J. Org.
Chem. 2014, 3, 1089-1096.
10-(4-(4-(1,4,7,10-tetraoxa-13-azacyclopentadecan-13-yl)-3-
methoxyphenyl)-1H-1,2,3-triazol-1-yl)-2,3,6,7-tetrahydro-1H,5H,11H-
pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11-one (8): Yield 20% (52 mg);
M.p.: 126°C (decomp.); 1H NMR (CDCl3, 300 MHz): δ = 8.72 (s, 1H),
8.32 (s, 1H), 7.47 (s, 1H), 7.38 (d, J = 7.7 Hz, 1H), 7.18 (d, J = 7.8 Hz,
1H), 6.99 (s, 1H), 3.94 (s, 3H), 3.80-3.33 (m, 20H), 3.32-3.28 (m, 4H),
2.90 (t, J = 6.4 Hz, 2H), 2.77 (t, J = 6.1 Hz, 2H), 2.02-1.92 ppm (m, 4H);
13C NMR (CDCl3, 75 MHz): δ = 157.04, 150.69, 147.19, 146.88, 134.65,
130.80, 125.84, 119.83, 119.72, 118.48, 118.40, 115.80, 115.39, 109.20,
109.10, 106.83, 106.06, 70.39, 70.18, 69.95, 69.88, 69.75, 55.65, 49.95,
49.53, 27.34, 21.02, 20.12, 20.08 ppm; HRMS (ESI): m/z calcd for
C34H41N5O7+H+: 632.3084 [M+H+]; found: 632.3058.
[10] K. Sivakumar, F. Xie, B. M. Cash, S. Long, H. N. Barnhill, Q. Wang,
Org. Lett. 2004, 6 (24), 4603-4606.
[11] a) J. D. Lewis, J. N. Moore, Dalton Trans. 2004, 1376-1385; b) L.-H.
Lee, V. Lynch, R. J. Lagow, J. Chem. Soc., Perkin Trans. 1 2000, 2805-
2809.
[12] J. Pietruszka, A. Witt, Synthesis 2006, 24, 4266-4268.
[13] For the synthesis of 3-azido-8-(dimethylamino)-2H-benzo[g]chromen-2-
one and for the determination of the Kd values see supporting
information.
[14] a) V. V. Rostovtsev, L. G. Green, V. V. Folkin, K. B. Sharpless, Angew.
Chem. Int. Ed. 2002, 41, 2596-2599; b) C. W. Tornoe, C. Christensen,
M. Meldal, J. Org. Chem. 2002, 67, 3057-3062.
3-(4-(4-(1,4,7,10-tetraoxa-13-azacyclopentadecan-13-yl)-3-
methoxyphenyl)-1H-1,2,3-triazol-1-yl)-8-(dimethylamino)-2H-
benzo[g]chromen-2-one (9): Yield 33% (86 mg); M.p.: 135°C
(decomp.); 1H-NMR (CDCl3, 300 MHz): δ = 8.78 (s, 1H), 8.58 (s, 1H),
7.94 (s, 1H), 7.83-7.75 (m, 1H), 7.50-7.32 (m, 3H), 7.24-7.21 (m, 1H),
7.13 (d, J = 8.9 Hz, 1H), 6.79 (s, 1H), 4.05-3.38 (m, 23H), 3.11 ppm (s,
6H); 13C-NMR (CDCl3, 125 MHz): δ = 156.57, 150.26, 149.86, 145.55,
137.40, 132.44, 129.85, 129.51, 123.87, 123.85, 120.35, 118.85, 118.62,
116.39, 113.18, 109.92, 109.50, 109.41, 109.30, 106.13, 103.95, 70.70,
70.50, 70.41, 70.31, 56.21, 55.77, 40.21 ppm; HRMS (ESI): m/z calcd for
C34H39N5O7+H+: 630.2928 [M+H+]; found: 630.2917.
[15] D. Rehm, A. Weller, Isr. J. Chem. 1970, 8, 259-271.
[16] For 1, 2 and 4 a reductive PET process from the ionophore to the
fluorophore has different GPET values according to the Rehm-Weller
[15]
equation GPET = Eox - Ered - E00 - Gion pair
.
The oxidation potential
Eox of 1 is 0.75 V, of 2 is 0.77 V, of 4 is 0.80 V, of 5 is 1.30 V and of 7 is
1.37 V, respectively. The reduction potential of 1, 2, 4, 5 and 7 Ered is –
1.90 V (Fc/Fc+ = 0.09 V in MeCN). In MeCN the E00 for 1, 2, 4, 5 and 7
ˆ
2.77 eV). The ion-pairing energy Gion pair is ca.
is found at 448 nm (
0.1 eV under our conditions. Finally: GPET (1) = -0.22 eV, GPET (2) = -
0.20 eV, GPET (4) = -0.17 eV,GPET (5) = +0.33 eV, GPET (7) = +0.39
eV.
Keywords: sodium • potassium • fluorescence • fluorescent
probes • crown compounds
[17] T. Lopez Arbeloa, F. Lopez Arbeloa, M. J. Tapia, I. Lopez Arbeloa, J.
Phys. Chem. 1993, 97, 4704-4707.
[18] G. Jones II, M. A. Rahman, J. Phy. Chem. 1994, 98, 13028-13037.
[1]
[2]
a) E. Murphy, D. A. Eisner, Circ. Res. 2009, 104, 292-303; b) D. M.
Bers, W. H. Barry, S. Despa, Cardiovasc. Res. 2003, 57, 897-912.
A. Minta, R. Y. Tsien, J. Biol. Chem. 1989, 264, 19449-19457.
For internal use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.